Only the wealthy can afford the most effective obesity drugs in Finland, doctor says
Finland’s most effective obesity medications, Wegovy and Mounjaro, are not covered by the national health insurance scheme Kela, while only the less effective Saxenda and Mysimba receive partial…
Read the full articleYou might also wanna read
Most obesity drugs do not improve quality of life or heart health
Treatment decisions should be individualised, balancing expected benefits, harms, treatment burden, costs, availability, and patient prefere
Study finds most weight loss drugs including Wegovy and Mounjaro ‘do not improve quality of life’
Wegovy pills found to have less positive impact on heart health than injectable counterparts
Novo gains head start on Lilly with European Commission approval of Wegovy pill
In Novo Nordisk and Eli Lilly’s competition to launch their respective GLP-1 obesity pills in the United States, the Danish ...
India approves Novo Nordisk’s obesity drug Wegovy for fatty liver disease
July 17 (Reuters) - Danish drugmaker Novo Nordisk said on Friday that India's drug regulator has approved its obesity drug Wegovy for the tr
Novo Nordisk’s obesity drug Wegovy gets CDSCO approval to treat liver condition
The product is the first and only GLP-1 for adults with fatty liver disease in India, Novo Nordisk says
GLP-1 Prescriptions Rise as U.S. Obesity Rates Show Modest Decline, New Data Indicates
As the rate of GLP-1 prescriptions in the U.S. has risen, the obesity rate has dropped.
gizmodo.com·1mo ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.